NASDAQ: HWKN
Hawkins Inc Stock

$161.59-3.92 (-2.37%)
Updated Jun 26, 2026
HWKN Price
$161.59
Fair Value Price
$282.81
Market Cap
$3.37B
52 Week Low
$117.98
52 Week High
$186.15
P/E
41.12x
P/B
6.31x
P/S
2.91x
PEG
4.11x
Dividend Yield
0.47%
Revenue
$1.08B
Earnings
$81.55M
Gross Margin
22.6%
Operating Margin
11.34%
Profit Margin
7.5%
Debt to Equity
0.85
Operating Cash Flow
$144M
Beta
0.82
Next Earnings
Jul 29, 2026
Ex-Dividend
N/A
Next Dividend
N/A

HWKN Overview

Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HWKN's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Chemical

Industry Rating
A
HWKN
Ranked
#42 of 52

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$5.19A
$45.12A
$12.19A
View Top Specialty Chemical Stocks

Be the first to know about important HWKN news, forecast changes, insider trades & much more!

HWKN News

Overview

Due Diligence Score

Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HWKN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HWKN ($161.59) is undervalued by 42.86% relative to our estimate of its Fair Value price of $282.81 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HWKN ($161.59) is significantly undervalued by 42.86% relative to our estimate of its Fair Value price of $282.81 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HWKN ($161.59) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more HWKN due diligence checks available for Premium users.

Valuation

HWKN fair value

Fair Value of HWKN stock based on Discounted Cash Flow (DCF)

Price
$161.59
Fair Value
$282.81
Undervalued by
42.86%
HWKN ($161.59) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HWKN ($161.59) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HWKN ($161.59) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HWKN price to earnings (PE)

For valuing profitable companies with steady earnings

Company
41.12x
Industry
10.23x
Market
12.39x
HWKN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HWKN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

HWKN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
6.31x
Industry
3.75x
HWKN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HWKN price to earnings growth (PEG)

For valuing profitable companies with growth potential

HWKN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

HWKN's financial health

Profit margin

Revenue
$265.9M
Net Income
$15.5M
Profit Margin
5.8%
HWKN's Earnings (EBIT) of $122.85M... subscribe to Premium to read more.
Interest Coverage Financials
HWKN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$986.3M
Liabilities
$452.3M
Debt to equity
0.85
HWKN's short-term assets ($231.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HWKN's long-term liabilities ($347.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HWKN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HWKN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$37.7M
Investing
-$19.5M
Financing
-$22.5M
HWKN's operating cash flow ($144.33M)... subscribe to Premium to read more.
Debt Coverage Financials

HWKN vs Specialty Chemical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HWKNC$3.37B-2.37%41.12x6.31x
FULA$3.40B+2.10%18.60x1.63x
WDFCC$3.34B+0.92%42.09x12.42x
AVNTB$3.48B+2.46%21.91x1.45x
CCC$3.12B-2.90%-7.57x14.51x

Hawkins Stock FAQ

What is Hawkins's quote symbol?

(NASDAQ: HWKN) Hawkins trades on the NASDAQ under the ticker symbol HWKN. Hawkins stock quotes can also be displayed as NASDAQ: HWKN.

If you're new to stock investing, here's how to buy Hawkins stock.

What is the 52 week high and low for Hawkins (NASDAQ: HWKN)?

(NASDAQ: HWKN) Hawkins's 52-week high was $186.15, and its 52-week low was $117.98. It is currently -13.19% from its 52-week high and 36.96% from its 52-week low.

How much is Hawkins stock worth today?

(NASDAQ: HWKN) Hawkins currently has 20,868,176 outstanding shares. With Hawkins stock trading at $161.59 per share, the total value of Hawkins stock (market capitalization) is $3.37B.

Hawkins stock was originally listed at a price of $5.78 in Dec 31, 1997. If you had invested in Hawkins stock at $5.78, your return over the last 28 years would have been 2,695.67%, for an annualized return of 12.63% (not including any dividends or dividend reinvestments).

How much is Hawkins's stock price per share?

(NASDAQ: HWKN) Hawkins stock price per share is $161.59 today (as of Jun 26, 2026).

What is Hawkins's Market Cap?

(NASDAQ: HWKN) Hawkins's market cap is $3.37B, as of Jun 29, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hawkins's market cap is calculated by multiplying HWKN's current stock price of $161.59 by HWKN's total outstanding shares of 20,868,176.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.